Skip to content

The NOR-COR Study for Coronary Prevention

The NOR-COR (NORwegian CORonary) Study: Identification of CHD Patients With Poor Adherence to Secondary Prevention and Their Perceived Needs for Follow-up

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02309255
Enrollment
975
Registered
2014-12-05
Start date
2014-02-28
Completion date
2015-04-30
Last updated
2015-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Secondary Coronary Prevention

Keywords

Secondary coronary prevention, Psychosocial factors, Cardiac rehabilitation

Brief summary

The NOR-COR study is a cross-sectional, observational study designed to explore a large number of cardiovascular, inflammatory, genetic, behavioral, and psychosocial factors (including anxiety, depression, quality of life) in 1369 patients with established coronary heart disease (CHD) hospitalized in the Sections for Cardiology at the hospitals in Drammen (n=722) and Vestfold (n=647). Study data from an extensive questionnaire, clinical and laboratory data, and sputum/saliva for genetic analyses will be collected. The main overall aim of the NOR-COR study is to develop new strategies to improve secondary prevention for underserved high risk patient-groups with CHD. The first study phase aims to collect information necessary to develop empirically based future secondary coronary prevention interventions. In a genetic sub-project markers associated with CHD and personality type will be explored. The study will evaluate current secondary preventive programs and explore the mechanisms that link behavioral, psychosocial, inflammatory, and genetic factors to poor prognosis. The study will in short term provide new knowledge potentially useful for increasing participation in current cardiac rehabilitation/secondary preventive programs. For a longer perspective these associations may be useful for design of new intervention programs to selected high risk patient groups whom may be in need of programs with different content and/or of longer duration than those currently being applied.

Interventions

OTHERno intervention

Sponsors

The Hospital of Vestfold
CollaboratorOTHER
Oslo University Hospital
CollaboratorOTHER
Kalmar County Hospital
CollaboratorOTHER
Vestre Viken Hospital Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

All patients aged 18-80 years with first or recurrent diagnosis or treatments for CHD: a) acute myocardial infarction \[ICD-10; I21\], b) coronary artery by-pass graft operation (CABG), or c) elective or emergency PCI \[ICD-10; I25\]) have been identified from hospital patient discharge lists (diagnostic lists) by searching chronologically after last admission the past three years. In patients with recurrent diagnosis the last event will define the event.

Exclusion criteria

* Cognitive impairment that would invalidate assessment including all patients living at nursing home and psychosis. * Short life expectancy (i.e. \<1 year) due to terminal heart (NYHA class 4), lung (chronic obstructive pulmonary disease GOLD 4)-, liver- or kidney disease (chronic kidney disease stage 5), malignant disease, or other reason. * Not able to understand and write the Norwegian language or refuse to give written informed consent to study participation.

Design outcomes

Primary

MeasureTime frame
Cardiovascular risk factors, lifestyle, and drug adherenceWithin 2 years after study inclusion

Secondary

MeasureTime frame
Readmission with a coronary event, acute myocardial infarctrion and cardiovascular mortalityWithin 5 years after study inclusion

Other

MeasureTime frame
The hospital anxiety and depression scale (HADS)Within 2 years after study inclusion

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026